These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36864097)

  • 1. A comparative study of smart nanoformulations of diethyldithiocarbamate with Cu
    Abu-Serie MM; Abdelfattah EZA
    Sci Rep; 2023 Mar; 13(1):3529. PubMed ID: 36864097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-metastatic breast cancer potential of novel nanocomplexes of diethyldithiocarbamate and green chemically synthesized iron oxide nanoparticles.
    Abu-Serie MM; Abdelfattah EZA
    Int J Pharm; 2022 Nov; 627():122208. PubMed ID: 36122615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior cuproptotic efficacy of diethyldithiocarbamate-Cu
    Abu-Serie MM; Barakat A; Ramadan S; Habashy NH
    Front Pharmacol; 2024; 15():1388038. PubMed ID: 39076585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction.
    Abu-Serie MM; Osuka S; Heikal LA; Teleb M; Barakat A; Dudeja V
    Front Pharmacol; 2024; 15():1363511. PubMed ID: 38720782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nanoformulated diethyldithiocarbamate complexes with biosynthesized or green chemosynthesized copper oxide nanoparticles: An in vitro comparative anticancer study.
    Abu-Serie MM; Eltarahony M
    Int J Pharm; 2021 Nov; 609():121149. PubMed ID: 34601057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted ferroptotic potency of ferrous oxide nanoparticles-diethyldithiocarbamate nanocomplex on the metastatic liver cancer.
    Abu-Serie MM
    Front Pharmacol; 2022; 13():1089667. PubMed ID: 36686682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy.
    Xiao C; Li J; Wang X; Li S; Xu C; Zhang Z; Hua A; Ding ZY; Zhang BX; Yang X; Li Z
    J Control Release; 2023 Apr; 356():288-305. PubMed ID: 36870542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells.
    Abu-Serie MM
    Sci Rep; 2018 Mar; 8(1):4617. PubMed ID: 29545617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids.
    Abu-Serie MM
    Nanomedicine (Lond); 2024; 19(11):979-994. PubMed ID: 38578787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Anti-Breast Cancer Effects of Green-Synthesized Zinc Oxide Nanoparticles Using Carob Extracts.
    Pouresmaeil V; Haghighi S; Raeisalsadati AS; Neamati A; Homayouni-Tabrizi M
    Anticancer Agents Med Chem; 2021; 21(3):316-326. PubMed ID: 32698752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress.
    Hsu NS; Tehei M; Hossain MS; Rosenfeld A; Shiddiky MJA; Sluyter R; Dou SX; Yamauchi Y; Konstantinov K
    ACS Appl Mater Interfaces; 2021 Jan; 13(2):2204-2217. PubMed ID: 33399455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine.
    Wang J; Lee JS; Kim D; Zhu L
    ACS Appl Mater Interfaces; 2017 Nov; 9(46):39971-39984. PubMed ID: 29076344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of zinc oxide nanoparticles using
    Umar H; Kavaz D; Rizaner N
    Int J Nanomedicine; 2019; 14():87-100. PubMed ID: 30587987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
    Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
    Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
    Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
    J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 19. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species.
    Akhtar MJ; Ahamed M; Kumar S; Khan MM; Ahmad J; Alrokayan SA
    Int J Nanomedicine; 2012; 7():845-57. PubMed ID: 22393286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.